News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

King Pharmaceuticals®, Inc. Announces the Discontinuation of Procanbid (R)


11/9/2007 2:38:11 PM

San Francisco, Calif. -- King Pharmaceuticals announces the discontinuation of Procanbid (Procanamide Hydrochloride Extended-Release Tablets). The company says the drug is being discontinued because of understanding about current therapy and due to the availability of alternative anti-arrhythmics.

Procanbid tablets are indicated for the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia.

To view a letter from the company, please visit: http://www.fda.gov/cder/drug/shortages/procanletter.pdf

Contact: Suvarna Bhatt at sbhatt@biospace.com.


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES